Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01308736 · ClinicalTrials.gov registry record · NA

Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit

A NA study of Tobacco Use Disorder, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
73
Enrollment target
1
Study location

NCT01308736 is a NA study of Tobacco Use Disorder that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 73 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01308736, a NA study of Tobacco Use Disorder, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target
1
Study location

Study Summary

The investigators will randomize smokers to receive 1) Varenicline + smoking cessation/reduction counseling or 2) Placebo pill + smoking cessation/reduction counseling. Neither the participants nor the research therapists/evaluators will know to which condition (active or placebo pill) the participants have been assigned i.e., a double-blind study). The medication and weekly counseling will occur for 28 days. Participants will complete assessment measures just before the start of treatment (baseline), at the end-of-treatment, at 1-month, 3-month, and at 6-months to determine if there are differences in tobacco use between treatment groups.

Conditions Studied

Interventions

  • DRUG Varenicline
  • DRUG Placebo pill

Study Locations (1)

New Jersey

  • Division of Addiction Psychiatry - New Brunswick

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2011-01
Est. Completion 2014-02
Phase NA

What the Registry Record Tells You About NCT01308736

The ClinicalTrials.gov registry entry for NCT01308736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (69% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Varenicline is the first listed.

NCT01308736 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT01308736 about?

NCT01308736 is a clinical study titled "Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit". The investigators will randomize smokers to receive 1) Varenicline + smoking cessation/reduction counseling or 2) Placebo pill + smoking cessation/reduction counseling. Neither the participants nor the research therapists/evaluators will know to which condition (active or placebo pill) the participa...

What is the current status of trial NCT01308736?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2011-01. Estimated completion is 2014-02.

What conditions does trial NCT01308736 study?

This clinical trial studies the following conditions: Tobacco Use Disorder.

What interventions are being tested in trial NCT01308736?

The interventions under investigation include: Varenicline (DRUG), Placebo pill (DRUG).

Who is sponsoring clinical trial NCT01308736?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01308736 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.